| Previous close | 34.70 |
| Open | 37.71 |
| Bid | 36.00 |
| Ask | 37.50 |
| Strike | 165.00 |
| Expiry date | 2024-01-19 |
| Day's range | 37.71 - 37.71 |
| Contract range | N/A |
| Volume | |
| Open interest | 525 |
- Motley Fool
2 Undervalued Stocks to Buy Today to Prepare for the Next Bull Market
Rewards that the next bull market will bring are being built right now by farsighted investors who can find opportunities among today's discounted stocks. While there's no telling exactly when a bull market will develop, planting the seeds of success by buying some shares of cheap yet high-quality companies out there right now is a good move. With that in mind, here are two businesses you're probably acquainted with that are priced for a no-brainer purchase -- and have a good shot at flourishing in the next bull market and beyond.
- Motley Fool
3 (Good) Reasons Warren Buffett Doesn't Invest in Biotech Stocks
There's a pretty good chance Warren Buffett knows a few things about investing that we don't. Let's take a look at three of his most likely arguments against buying biotechs. Biotech stocks are risky, and there isn't really any way of de-risking their line of business, both of which are things that Buffett almost certainly hates about them.
- Simply Wall St.
Shareholders may not want to ignore the US$4.3m worth sales made by Moderna, Inc. (NASDAQ:MRNA) insiders this past year
While Moderna, Inc. ( NASDAQ:MRNA ) shareholders have had a good week with the stock up 8.5%, they shouldn't let their...
